In the Boardroom
Refine Search
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
French pharma major Sanofi has named Brian Foard as head of its Specialty Care Global Business Unit (GBU). 9 January 2024
Pharmaceutical
Sweden-based rare diseases company Calliditas Therapeutics has appointed Maria Törnsén to the position of president North America. 9 January 2024
Biotechnology
CRISPR genome-editing company Caribou Biosciences has appointed Tim Kelly to the newly-created position of chief technology officer. 8 January 2024
Pharmaceutical
Paris, France-based cardiology specialist Corteria Pharmaceuticals has announced the appointment of Dr Mark Pruzanski, as chairman of its board of directors. 6 January 2024
Pharmaceutical
Japanese drugmaker Sosei has appointed a chief operating officer, Toshihiro Maeda, a new role at the company. 5 January 2024
Biotechnology
Boston, USA-based biotech start-up Kojin Therapeutics has announced the appointment of Harvey Berger as its new chairman, president and chief executive (CEO). 5 January 2024
Biotechnology
French immuno-oncology company Innate Pharma today announced that it has strengthened its leadership and corporate governance with the appointment of two new executive board members. 4 January 2024
Biotechnology
Spanish genetic medicines company SpliceBio today announced the appointment of Aniz Girach as chief medical officer (CMO). 3 January 2024
Pharmaceutical
UK-based Arecor Therapeutics has announced the appointment of Dr Helen Parris as senior vice president, commercial and general manager of Tetris Pharma. 3 January 2024
Biotechnology
Cambridge, USA-based mRNA cell engineering focused biotech Eterna Therapeutics has appointed Sanjeev Luther as president and chief executive and a member of the company's board of directors, effective January 1, 2024. 21 December 2023
Biotechnology
Danish gene expert Hervolution Therapeutics has appointed J Robert Coleman as chief executive. 20 December 2023
Biotechnology
Avacta Group, a UK life sciences company developing innovative, targeted oncology drugs and diagnostics, has appointed Simon Bennett as chief business officer of the therapeutics division. 19 December 2023
Pharmaceutical
Vicore Pharma, a Swedish pharma company seeking to unlock the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), has announced that Bertil Lindmark will join as chief medical officer. 18 December 2023
Biotechnology
French immuno-oncology company Innate Pharma has announced the resignation of chief executive Mondher Mahjoubi. 18 December 2023
Biotechnology
Switzerland-based Asceneuron has announced the appointment of Abbas Hussain as its new chairman of to its board of directors. 18 December 2023
Biotechnology
US provider of chemical biology technologies Totus Medicines has announced the appointment of Nassim Usman as president and chief executive. 16 December 2023
Biotechnology
From January 1, 2024, Ashley Magargee’s role as chief executive of the Roche subsidiary Genentech will become permanent. 15 December 2023
Biotechnology
Former Novartis executive James Bradner has joined Amgen as executive vice president of research and development (R&D), and chief scientific officer. 14 December 2023
Biotechnology
Californian antibody specialist Electra Therapeutics has appointed Kathy Dong as president and chief executive, replacing current CEO Adam Rosenthal. 13 December 2023
Biotechnology
US mRNA medicines company Moderna has announced changes to its operating model to bring focus to its short- and long-term business goals. 13 December 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze